top of page
Embryonic Stem Cells

About Us

GelMEDIX Inc. is an early-stage biotechnology company leveraging its hydrogel platform to develop ocular and regenerative therapies that can restore vision.

GelMEDIX was founded after multiple years of fruitful academic collaboration between our co-founders Reza Dana (Mass. Eye And Ear, Harvard Med. School) and Nasim Annabi (UCLA). 

Home: About Us
RPE Injection Blow up.png

Our Technology

PROPRIETARY HYDROGEL PLATFORM

Our proprietary photo-crosslinked hydrogels uniquely enable
bioadhesion, tissue regeneration, tunable mechanics, and therapeutic loading across modalities from small molecules to cell and gene therapies.

Our lead program is an integrated hydrogel cell therapy designed to
restore vision for macular degeneration patients with Dry AMD and GA.

Home: Our Technology

Our Team

Art Driscoll headshot_edited.jpg

CHIEF DEVELOPMENT OFFICER

Art has over 25 years of experience in medtech product development with a focus on biomaterials and drug delivery. Most recently, he spent 10 years as the VP of R&D at Ocular Therapeutix bringing ReSure and Dextenza to commercial launch and multiple other products from concept through to clinical study.

Picture1.jpg

CO-FOUNDER

Dr. Dana is the Chief of Cornea at Mass. Eye and Ear and Chair in Ophthalmology at Harvard Medical School. He is the founder of multiple ophthalmic focused companies with $100m+ raised to date with 15 INDs.

Picture2jpg.jpg

CO-FOUNDER

Dr. Ananbi is an Asst. Professor of Chemical and Bimolecular Engineering at UCLA. She is the recipient of multiple awards for young investigators from the Society for Biomaterials and the American Institute for Chemical Engineers.

headshot (1).jpeg

SR. MANAGER CORPORATE DEVELOPMENT AND OPERATIONS

Max works at the intersection of science and business operations for GelMEDIX. He has a PhD in Medical Engineering from MIT with a research background in drug delivery.

1591891305772_edited.jpg

SCIENTIST - BIOMATERIALS

Noel is an expert in biomaterials engineering and drug release. He holds a PhD in Biomedical Engineering from Brown University with a research focus on responsive hydrogel systems.

1672777492314 (1)_edited.jpg

SCIENTIST - STEM CELL BIOLOGY

Alex is an expert in stem cell differentiation and neural cell biology. He holds a PhD in Neuroscience from the University of Michigan with a research focus in neuroplasticity.

1634371077624_edited.jpg

RESEARCH ASSOCIATE/ENGINEER

Arthur is biomedical engineer with a focus on drug release with a BS in Biomedical Engineering from Drexel University.

Home: Our Team

Partners and Advisors

Picture4.jpg

Michael Cima, PhD

INDEPENDENT DIRECTOR
MIT PROFESSOR, SERIAL ENTREPRENEUR

Picture5.jpg

Dean Eliott, MD

CLINICAL ADVISOR
DIR. EMERETIS RETINA, MASS. EYE AND EAR

Picture6.png

Brian Ballios, MD, PhD

CLINICAL ADVISOR
PHYSICIAN SCIENTIST UNIV. OF TORONTO

Picture3_edited.png

Safar Partners

LEAD INVESTOR

Home: Our Team

Open Positions

Scientist Pipetting

(Sr.) Research Associate - Stem Cell Biology

FULL TIME

 We are seeking an experienced, creative, and motivated biologist to be a key member of our growing, cross-functional team working on the development and optimization of stem cell derived therapies and implantable formulations. A BS/MS in a biological science discipline and experience with mammalian cell culture is required, with 2-3 years industry experience required for the Senior RA level. For more information, or to apply now, please email a resume and cover letter to hr@gelmedix.com 

Home: Join Us

Contact

700 Main St North, c/o LabCentral, Cambridge, MA 02139

Microscope
Home: Contact

News

Scientist Pipetting

HTL Announces Its Incubator's Equity Investment In GelMEDIX, An Early-Stage Biotech Aiming At Revolutionizing Ocular And Regenerative Therapies

MARCH 10, 2022

Home: News
bottom of page